| __timestamp | Alpine Immune Sciences, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 675200000 |
| Thursday, January 1, 2015 | 6844000 | 771800000 |
| Friday, January 1, 2016 | 8586000 | 1205500000 |
| Sunday, January 1, 2017 | 6079000 | 1146500000 |
| Monday, January 1, 2018 | 8362000 | 1125800000 |
| Tuesday, January 1, 2019 | 9467000 | 1166100000 |
| Wednesday, January 1, 2020 | 10899000 | 1175500000 |
| Friday, January 1, 2021 | 14560000 | 1111400000 |
| Saturday, January 1, 2022 | 17968000 | 1210100000 |
| Sunday, January 1, 2023 | 22222000 | 1274600000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of the pharmaceutical and biotechnology sectors, understanding operational efficiency is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Alpine Immune Sciences, Inc. and Perrigo Company plc from 2014 to 2023.
Alpine Immune Sciences, Inc. has seen a significant increase in SG&A expenses, growing nearly tenfold from 2014 to 2023. This upward trend reflects the company's aggressive expansion and investment in administrative capabilities.
Conversely, Perrigo Company plc, a more established player, has maintained a relatively stable SG&A expense profile, with a modest 89% increase over the same period. This stability suggests a mature operational strategy focused on efficiency.
The contrasting trends between these two companies highlight different strategic approaches in managing operational costs, offering valuable insights for investors and industry analysts.
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Perrigo Company plc
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Operational Costs Compared: SG&A Analysis of Blueprint Medicines Corporation and Alpine Immune Sciences, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Corcept Therapeutics Incorporated and Perrigo Company plc: SG&A Spending Patterns Compared
Axsome Therapeutics, Inc. or Perrigo Company plc: Who Manages SG&A Costs Better?
Alpine Immune Sciences, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Apellis Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
Viking Therapeutics, Inc. and Perrigo Company plc: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.